Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes

BACKGROUND: SGLT2 inhibitors are a new class of drugs that act by inhibiting glucose reabsorption in the proximal renal tubules. Many trials have demonstrated their effectiveness in reducing glycated hemoglobin (HbA1c) and weight, but they have never been examined in Arab or Emirati populations. MET...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Med Res
Main Authors: Bashier, Alaaeldin, Khalifa, Azza Abdulaziz, Rashid, Fauzia, Abdelgadir, Elamin Ibrahim, Al Qaysi, Amina Adil, Ali, Razan, Eltinay, Ahmed, Nafach, Jalal, Alsayyah, Fatima, Alawadi, Fatheya
Format: Artigo
Language:Inglês
Published: Elmer Press 2017
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5412523/
https://ncbi.nlm.nih.gov/pubmed/28496550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2976w
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items